Latest proteinuria Stories
DENVER, Nov. 22, 2010 /PRNewswire/ -- On November 20 at the American Society of Nephrology (ASN) 43rd Annual Meeting, interim results presented from an ongoing, randomized prospective study conducted independently by James A.
DENVER, Nov. 22, 2010 /PRNewswire/ -- On November 20 at the American Society of Nephrology 43rd Annual Meeting, Columbia University Assistant Professor of Clinical Medicine Andrew Bomback, MD, presented results from a patient case series assessing the potential therapeutic value of H.P.
ANAHEIM, Calif., Oct. 15 /PRNewswire-FirstCall/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today announced the U.S. Food and Drug Administration (FDA) has approved Questcor's supplemental new drug application (sNDA) for H.P.
UNION CITY, Calif., Sept. 20 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) announced today that it will present at the UBS Global Life Sciences Conference on Wednesday, September 22, 2010 at The Grand Hyatt Hotel in New York. Don M.
Poor kidney function is common among injection drug users, particularly those with HIV.
UNION CITY, Calif., July 29 /PRNewswire-FirstCall/ -- Questcor Pharmaceuticals, Inc.
A morning urine test is superior to all other tests for detecting declining kidney performance in patients with diabetic kidney disease.
The widely used cancer drug bevacizumab (known popularly as Avastin) may cause severe loss of protein from the kidney into the urine that can lead to significant kidney damage and can compromise the efficacy of cancer treatment.
WASHINGTON, March 19 /PRNewswire-USNewswire/ -- No matter what Washington does on health reform, there's a lot you can do to reform your own health -- and two of the best places to start are your kidneys. So says Dr.
The drug avosentan substantially reduces urinary protein loss in people with type 2 diabetes and kidney disease, but the drug causes serious side effects, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN).